BT

BrightSpring Health Services, Inc.

BTSGHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$12.91B
+28.2% YoY
Net Income
$190.7M
+1155.6% YoY
EBITDA
$459.5M
+53.3% YoY
Free Cash Flow
$1.03B

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 31 MACD Positive CrossoverHistogram +0.1868, positive momentum
Aug 29 MACD Positive CrossoverHistogram +0.1868, positive momentum
About BrightSpring Health Services, Inc.

Headquartered within the healthcare sector, BrightSpring Health Services, Inc. focuses on Health Information Services services and products. BrightSpring Health Services, Inc. The company carries a $12.38B market cap, placing it firmly in the large-cap category. operates as a home and community-based healthcare services platform in the United States.

Where BTSG stands vs its 150-day and 200-day moving averages

As of the August 31, 2026 close, BTSG finished 10.03% above its 150-day moving average ($53.74) and 19.62% above its 200-day moving average ($49.43). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is BTSG overbought or oversold?

At the August 31, 2026 close, BTSG's RSI(14) was 44.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$12.38B
P/E (TTM)55.86
Fwd P/E27.46
EPS$1.12
Beta1.85
52W Change+116.3%
ROE13.0%
Analysis

On the balance sheet, BTSG has $550.4M in cash with $2.39B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $1.03B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 13.0%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $7.72B (2022) to $12.91B (2025), reflecting a 67% increase over the period.

With a beta above 1.5, BTSG tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for BrightSpring Health Services, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms